159 related articles for article (PubMed ID: 7739851)
21. Caffeine clearance test: a quantitative liver function assessment in patients with liver cirrhosis.
Shyu JK; Wang YJ; Lee SD; Lu RH; Lo KJ
Zhonghua Yi Xue Za Zhi (Taipei); 1996 May; 57(5):329-34. PubMed ID: 8768380
[TBL] [Abstract][Full Text] [Related]
22. Caffeine clearance in patients with chronic viral hepatitis: before and after interferon therapy.
Wittayalertpanya S; Mahachai V
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S189-96. PubMed ID: 11529334
[TBL] [Abstract][Full Text] [Related]
23. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
Fasoli A; Giannini E; Botta F; Romagnoli P; Risso D; Celle G; Testa R
Hepatogastroenterology; 2000; 47(31):234-8. PubMed ID: 10690614
[TBL] [Abstract][Full Text] [Related]
24. [One point determination of oral caffeine clearance in patients with liver diseases].
Richter E; Brachtel D; Hofstetter G; Joeres R; Klinker H; Junggeburth J; Epping J; Zilly W
Z Gastroenterol; 1988 Dec; 26(12):744-9. PubMed ID: 3149826
[TBL] [Abstract][Full Text] [Related]
25. Serum leptin levels in patients with nonalcoholic chronic liver disease.
Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
[TBL] [Abstract][Full Text] [Related]
26. Hepatic and blood lead levels in patients with chronic liver disease.
Castilla L; Castro M; Grilo A; Guerrero P; Lopez-Artiguez M; Soria ML; Martinez-Parra D
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):243-9. PubMed ID: 7743306
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of trapidil (Rocornal) in patients with chronic liver disease.
Berndt A; Pönicke K; Weiss M
Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):492-3. PubMed ID: 1490801
[TBL] [Abstract][Full Text] [Related]
28. Caffeine clearance by enzyme multiplied immunoassay technique: a simple, inexpensive, and useful indicator of liver function.
McDonagh JE; Nathan VV; Bonavia IC; Moyle GR; Tanner AR
Gut; 1991 Jun; 32(6):681-4. PubMed ID: 2060878
[TBL] [Abstract][Full Text] [Related]
29. Relationship of blood trace elements to liver damage, nutritional status, and oxidative stress in chronic nonalcoholic liver disease.
Loguercio C; De Girolamo V; Federico A; Feng SL; Crafa E; Cataldi V; Gialanella G; Moro R; Del Vecchio Blanco C
Biol Trace Elem Res; 2001 Sep; 81(3):245-54. PubMed ID: 11575681
[TBL] [Abstract][Full Text] [Related]
30. Decision-making model for a non-invasive diagnosis of compensated liver cirrhosis.
Marmo R; Romano M; de Sio I; Peduto A; Caporaso N; Persico M; Coltorti M
Ital J Gastroenterol; 1993 Jan; 25(1):1-8. PubMed ID: 8428017
[TBL] [Abstract][Full Text] [Related]
31. Caffeine elimination: a test of liver function.
Wang T; Kleber G; Stellaard F; Paumgartner G
Klin Wochenschr; 1985 Nov; 63(21):1124-8. PubMed ID: 4079279
[TBL] [Abstract][Full Text] [Related]
32. [Malondialdehyde concentration in blood plasma of patients with liver diseases].
Müller G; Rahfeld B; Jannasch M
Z Gesamte Inn Med; 1992 Jun; 47(6):263-5. PubMed ID: 1642026
[TBL] [Abstract][Full Text] [Related]
33. [The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease].
Kwon JH; Park ST; Kim GD; You CR; Kim JD; Woo HY; Jang JW; Kim CW; Bae SH; Choi JY; Yoon SK
Korean J Hepatol; 2009 Mar; 15(1):59-69. PubMed ID: 19346786
[TBL] [Abstract][Full Text] [Related]
34. Half-life time or clearance of indocyanine green in patients with liver disease.
Gilmore IT; Marigold JH; Thompson RP
Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
[TBL] [Abstract][Full Text] [Related]
35. Caffeine clearance in patients with hepatocellular carcinoma after transcatheter oily chemoembolization treatment.
Thong-Ngam D; Thumvijit L; Tangkijvanich P; Janchai A; Mahachai V; Wittayalertpanya S
J Med Assoc Thai; 2002 Dec; 85(12):1280-7. PubMed ID: 12678165
[TBL] [Abstract][Full Text] [Related]
36. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease.
Gonzàlez-Quintela A; Alende MR; Gamallo R; Gonzàlez-Gil P; López-Ben S; Tomé S; Otero E; Torre JA
Hepatogastroenterology; 2003; 50(54):2121-6. PubMed ID: 14696478
[TBL] [Abstract][Full Text] [Related]
37. Influence of smoking on cotinine and caffeine plasma levels in patients with alcoholic liver cirrhosis.
Langmann P; Bienert A; Zilly M; Väth T; Richter E; Klinker H
Eur J Med Res; 2000 May; 5(5):217-21. PubMed ID: 10806124
[TBL] [Abstract][Full Text] [Related]
38. Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients.
Mahmoud M; Abdel-Kader R; Hassanein M; Saleh S; Botros S
Eur J Pharmacol; 2007 Aug; 569(3):222-7. PubMed ID: 17628532
[TBL] [Abstract][Full Text] [Related]
39. Fasting plasma caffeine concentration. A guide to the severity of chronic liver disease.
Wahlländer A; Renner E; Preisig R
Scand J Gastroenterol; 1985 Nov; 20(9):1133-41. PubMed ID: 4089523
[TBL] [Abstract][Full Text] [Related]
40. Clinical value of the determination of fasting glycocholic acid serum levels in patients with liver diseases. A comparison with standard liver tests.
Collazos J; Mendarte U; De Miguel J
Gastroenterol Clin Biol; 1993; 17(2):79-82. PubMed ID: 8500713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
